D
Day One Biopharmaceuticals, Inc.
Q4 2025 earnings expected
Quarter
Oct – Dec
Expected
March 1, 2026(ET)
Revenue
This quarter$54M
Analyst estimate$50M▲ +7.8%
Year ago (Dec '24)$29M▲ +83.9%
EPS
This quarter-$0.20
Analyst estimate-$0.15▼ -34.3%
Year ago (Dec '24)-$0.69▲ +71.0%
Revenue Growth Trajectory
+84%YoY
Last 6 quarters · 7 analysts